Louisiana 2024 2024 Regular Session

Louisiana Senate Bill SB148 Introduced / Bill

                    SLS 24RS-311	ORIGINAL
2024 Regular Session
SENATE BILL NO. 148
BY SENATOR MIZELL 
HEALTH/ACC INSURANCE. Provides relative to postpartum depression. (8/1/24)
1	AN ACT
2 To amend and reenact R.S. 22:1053(K) and (L) and R.S. 40:1123.2 and to enact R.S.
3 22:1053(M) and 1059.4 and R.S. 46:460.34(D) and 974.1, relative to postpartum
4 depression; to provide for the application of step therapy and fail first protocols to
5 drugs prescribed for postpartum depression; to provide for health insurance coverage
6 for postpartum depression screenings; to provide for the duties of certain healthcare
7 professionals; to provide for Medicaid coverage of postpartum depression
8 screenings; to provide for definitions; to provide for technical changes; to provide
9 for applicability; to provide for the duties of the Louisiana Department of Health;
10 and to provide for related matters.
11 Be it enacted by the Legislature of Louisiana:
12 Section 1. R.S. 22:1053(K) and (L) are hereby amended and reenacted and R.S.
13 22:1053(M) and 1059.4 are hereby enacted to read as follows:
14 §1053. Requirement for coverage of step therapy or fail first protocols
15	*          *          *
16	K.(1) No health coverage plan shall use step therapy or fail first protocols
17 as the basis to restrict any prescription benefit for a drug approved by the
Page 1 of 6
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 148
SLS 24RS-311	ORIGINAL
1 United States Food and Drug Administration for the treatment of postpartum
2 depression.
3	(2) The provisions of this Subsection shall not apply if the preferred drug
4 or drug regimen is considered clinically equivalent for therapy, contains the
5 identical active ingredient or ingredients, and is proven to have the same
6 efficacy. For purposes of this Subsection, different salts proven to have the same
7 efficacy shall not be considered as different active ingredients.
8	(3) The treating healthcare provider shall inform the health coverage
9 plan that the condition being treated is postpartum depression when requesting
10 authorization.
11	L.(1) If a prescribed drug is denied by a health coverage plan based upon step
12 therapy or fail first protocols, the health coverage plan shall provide the prescriber
13 with a list of the alternative comparable formulary medications in writing and
14 attached to the letter of denial of prescription drug coverage.
15	(2) It shall be deemed sufficient to meet the requirements of this Subsection
16 if a health coverage plan includes the information required by this Subsection in the
17 denial letter sent by the health coverage plan or its agent. For any request made by
18 providers utilizing electronic health records with capabilities, the notice may be sent
19 electronically.
20	(3) Simple notification of the availability and location of the formulary shall
21 not be deemed sufficient to meet the requirements of this Subsection.
22	L. M. As used in this Section, the following definitions shall apply:
23	(1) "Health coverage plan" means:
24	(a) An individual or group plan or program which is established by contract,
25 certificate, law, plan, policy, subscriber agreement, or by any other method and
26 which is entered into, issued, or offered for the purpose of arranging for, delivering,
27 paying for, providing, or reimbursing any of the costs of health or medical care,
28 including pharmacy services, drugs, or devices.
29	(b) Any hospital, health, or medical expense insurance policy, hospital or
Page 2 of 6
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 148
SLS 24RS-311	ORIGINAL
1 medical service contract, employee welfare benefit plan, contract or agreement with
2 a health maintenance organization or a preferred provider organization, health and
3 accident insurance policy, or any other insurance contract of this type, including a
4 group insurance plan and the Office of Group Benefits programs.
5	(c) Any plan that is subject to the provisions of this Section which is
6 administered by a pharmacy benefit manager.
7	(2) "Stage-four advanced, metastatic cancer" means cancer that has spread
8 from the lymph nodes or other areas or parts of the body and "associated conditions"
9 means the symptoms or side effects associated with stage-four advanced, metastatic
10 cancer or its treatment.
11	*          *          *
12 §1059.4. Required coverage for postpartum mental health screenings
13	A. Any health coverage plan issued for delivery, delivered, renewed, or
14 otherwise contracted for in this state shall include coverage of screenings for
15 postpartum depression or related mental health disorders as provided for in
16 R.S. 40:1123.3.
17	B. For purposes of this Section, "health coverage plan" means any
18 hospital, health, or medical expense insurance policy, hospital or medical
19 service contract, employee welfare benefit plan, contract, or other agreement
20 with a health maintenance organization or a preferred provider organization,
21 health and accident insurance policy, or any other insurance contract of this
22 type in this state, including a group insurance plan, a self-insurance plan, and
23 the Office of Group Benefits programs. "Health coverage plan" shall not
24 include a plan providing coverage for excepted benefits as defined in R.S.
25 22:1061, limited benefit health insurance plans, and short-term policies that
26 have a term of less than twelve months.
27 Section 2. R.S. 40:1123.2 is hereby amended and reenacted to read as follows:
28 §1123.2. Awareness
29	A. In accordance with this Part, all hospitals and birthing centers that provide
Page 3 of 6
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 148
SLS 24RS-311	ORIGINAL
1 labor and delivery services shall, prior to discharge following pregnancy, provide
2 pregnant women and their family members information about perinatal mood and
3 anxiety disorders, including the symptoms, treatment, and available resources. The
4 Louisiana Department of Health bureau of family health, in cooperation with the
5 office of behavioral health, shall make such information available to hospitals and
6 birthing centers and shall include this information on the department's website.
7	B. Any healthcare provider who provides postnatal care or pediatric
8 infant care services shall make available the information provided for in
9 Subsection A of this Section to any woman who presents with signs of a
10 maternal mental health disorder, including but not limited to any woman
11 determined to be likely suffering from postpartum depression based on the
12 screenings for postpartum depression or related mental health disorders
13 administered pursuant to R.S. 40:1123.3.
14 Section 3. R.S. 46:460.34(D) and 974.1 are hereby enacted to read as follows:
15 §460.34. Step therapy; fail first protocols; requirements; prohibition
16	*          *          *
17	D.(1) A managed care organization shall not use step therapy or fail first
18 protocols as the basis to restrict any prescription benefit for a drug approved
19 by the United States Food and Drug Administration for the treatment of
20 postpartum depression.
21	(2) The provisions of this Subsection shall not apply if the preferred drug
22 or drug regimen is considered clinically equivalent for therapy, contains the
23 identical active ingredient or ingredients, and is proven to have the same
24 efficacy. For purposes of this Subsection, different salts proven to have the same
25 efficacy shall not be considered as different active ingredients.
26	(3) The treating healthcare provider shall inform the managed care
27 organization that the condition being treated is postpartum depression when
28 requesting authorization.
29	*          *          *
Page 4 of 6
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 148
SLS 24RS-311	ORIGINAL
1 §974.1. Postpartum depression; Medicaid coverage; screenings; step therapy
2	limitations
3	A. The screenings for postpartum depression or related mental health
4 disorders provided for in R.S. 40:1123.3 shall be a covered service in the
5 medical assistance program.
6	B. A managed care organization participating in the medical assistance
7 program shall not use step therapy or fail first protocols as the basis to restrict
8 any prescription benefit for a drug approved by the United States Food and
9 Drug Administration for the treatment of postpartum depression as provided
10 in R.S. 46:460.34.
11	C. For the purposes of this Section, "medical assistance program" means
12 the medical assistance program provided for in Title XIX of the Social Security
13 Act as administered by the Louisiana Department of Health.
14 Section 4. The provisions of Section 1 of this Act apply to any new policy, contract,
15 program, or health coverage plan issued on and after January 1, 2025. Any policy, contract,
16 or health coverage plan in effect prior to January 1, 2025, shall convert to conform to the
17 provisions of Section 1 of this Act on or before the renewal date, but no later than January
18 1, 2026.
19 Section 5. The Louisiana Department of Health shall take all actions necessary to
20 make the coverage required by the provisions of Section 3 of this Act available to all persons
21 eligible for such coverage on or before January 1, 2025.
The original instrument and the following digest, which constitutes no part
of the legislative instrument, were prepared by Brandi Cannon.
DIGEST
SB 148 Original 2024 Regular Session	Mizell
Present law provides certain requirements for implementation of step therapy or fail first
protocols used by any commercial health coverage plan. 
Proposed law retains present law and further prohibits a commercial health coverage plan
from using step therapy or fail first protocols as the basis to restrict any prescription benefit
for a drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of
postpartum depression. Proposed law does not apply if the preferred drug or drug regimen
is considered clinically equivalent for therapy, contains the identical active ingredient or
ingredients, and is proven to have the same efficacy.
Page 5 of 6
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 148
SLS 24RS-311	ORIGINAL
Proposed law requires any commercial health coverage plan issued for delivery, delivered,
renewed, or otherwise contracted for in this state to include coverage of screenings for
postpartum depression or related mental health disorders as required by present law.
Proposed law applies to any new policy, contract, program, or health coverage plan issued
on or after Jan. 1, 2025, and requires any policy, contract, or health coverage plan in effect
prior to Jan. 1, 2025, to convert to conform to the provisions of proposed law on or before
the renewal date, but no later than Jan. 1, 2026.
Present law requires all hospitals and birthing centers that provide labor and delivery
services to provide pregnant women and their family members information about perinatal
mood and anxiety disorders. Present law requires the La. Department of Health to make the
information available to hospitals and birthing centers, including on the department's
website.
Proposed law retains present law and further requires any healthcare provider who provides
postnatal care or pediatric infant care services to make available the information to any
woman who presents with signs of a maternal mental health disorder, including but not
limited to postpartum depression.
Present law provides certain requirements for implementation of step therapy or fail first
protocols used by any managed care organization participating in the Louisiana Medicaid
program. 
Proposed law retains present law and further prohibits a Medicaid managed care
organization from using step therapy or fail first protocols as the basis to restrict any
prescription benefit for a drug approved by the FDA for the treatment of postpartum
depression. Proposed law does not apply if the preferred drug or drug regimen is considered
clinically equivalent for therapy, contains the identical active ingredient or ingredients, and
is proven to have the same efficacy.
Proposed law provides that the screenings for postpartum depression or related mental health
disorders required in present law shall be a covered service in the Louisiana Medicaid
program.
Proposed law requires the La. Department of Health to take all actions necessary to make
the coverage required by proposed law available to all persons eligible for such coverage on
or before Jan. 1, 2025.
Effective August 1, 2024.
(Amends R.S. 22:1053(K) and (L) and R.S. 40:1123.2; adds R.S. 22:1053(M) and 1059.4
and R.S. 46:460.34(D) and 974.1)
Page 6 of 6
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.